Neuburgh Advisers LLC raised its stake in Teleflex Incorporated (NYSE:TFX) by 3.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,088 shares of the medical technology company’s stock after buying an additional 32 shares during the period. Neuburgh Advisers LLC’s holdings in Teleflex were worth $360,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of TFX. First Trust Advisors LP increased its holdings in shares of Teleflex by 247.5% in the first quarter. First Trust Advisors LP now owns 181,850 shares of the medical technology company’s stock valued at $54,948,000 after buying an additional 129,524 shares in the last quarter. Marshall Wace North America L.P. raised its stake in Teleflex by 32.2% during the 1st quarter. Marshall Wace North America L.P. now owns 494,782 shares of the medical technology company’s stock valued at $149,502,000 after purchasing an additional 120,411 shares during the period. C WorldWide Group Holding A S acquired a new stake in Teleflex during the 2nd quarter valued at $14,902,000. Northern Trust Corp raised its stake in Teleflex by 10.1% during the 1st quarter. Northern Trust Corp now owns 481,082 shares of the medical technology company’s stock valued at $145,364,000 after purchasing an additional 44,093 shares during the period. Finally, Braun Stacey Associates Inc. acquired a new stake in Teleflex during the 2nd quarter valued at $13,794,000. 90.67% of the stock is currently owned by institutional investors.
Several analysts have issued reports on TFX shares. Leerink Swann set a $405.00 target price on shares of Teleflex and gave the company a “buy” rating in a research note on Wednesday, September 4th. Needham & Company LLC reissued a “buy” rating and set a $403.00 target price (up from $325.00) on shares of Teleflex in a research note on Friday, August 2nd. JMP Securities boosted their target price on shares of Teleflex from $325.00 to $395.00 and gave the company a “market outperform” rating in a research note on Monday, August 5th. Wells Fargo & Co started coverage on shares of Teleflex in a research note on Tuesday, June 11th. They set an “outperform” rating and a $345.00 target price on the stock. Finally, ValuEngine downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Teleflex currently has a consensus rating of “Buy” and an average price target of $374.45.
Shares of NYSE TFX traded down $2.35 during mid-day trading on Thursday, reaching $336.42. The company had a trading volume of 5,298 shares, compared to its average volume of 333,212. Teleflex Incorporated has a twelve month low of $226.02 and a twelve month high of $373.90. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.59 and a current ratio of 2.52. The stock has a market capitalization of $15.80 billion, a PE ratio of 34.00, a price-to-earnings-growth ratio of 2.21 and a beta of 1.00. The stock’s 50 day moving average is $359.21 and its 200-day moving average is $318.85.
Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, August 1st. The medical technology company reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.59 by $0.07. Teleflex had a net margin of 10.78% and a return on equity of 18.57%. The business had revenue of $652.50 million for the quarter, compared to the consensus estimate of $637.06 million. During the same period in the prior year, the business posted $2.47 earnings per share. Teleflex’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Teleflex Incorporated will post 11.03 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Thursday, August 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Wednesday, August 14th. Teleflex’s dividend payout ratio (DPR) is presently 13.74%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.
Read More: How does a margin account work?
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.